Different injectable products have highly divergent properties, associated risks, and injection requirements. The der- masurgeon should be suitably experienced to select and use these products correctly.
The approach to soft tissue augmentation has evolved dramatically in recent years. With a greater appreciation for changes in facial soft tissue contours that occur with age has come an expansion of the role for fillers in rejuvenation of the midface. Ove
PLLA-induced augmentation is most likely based on capsule formation orchestrating macrophages, (myo-)fibroblasts, and collagen type I and III fibres. We observed considerably slower degradation of PLLA particles than described previously. Thus PLLA partic
